Glazer Capital LLC’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Glazer Capital LLC’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,320,748	Closed	-$69.3M	–	505
2020 Q3	$69.3M	Buy	+1,320,748	New	+$54.7M	3.39%	3

Glazer Capital LLC's MNTA Position: Q4 2020 in Review

Glazer Capital LLC sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 1,320,748 shares — an estimated $69.3M sold.

Glazer Capital LLC first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $69.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Glazer Capital LLC reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Glazer Capital LLC sold 1,320,748 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $69.3M.
Glazer Capital LLC first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Glazer Capital LLC's Momenta Pharmaceuticals, Inc. position peaked at $69.3M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Glazer Capital LLC's 13F filing for Q4 2020, filed 16 Feb 2021.